BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6830203)

  • 1. Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans.
    Smith CR; Lietman PS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):133-7. PubMed ID: 6830203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
    Smith CR; Lipsky JJ; Lietman PS
    Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
    Gatell JM; San Miguel JG; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta MT; Farré M; Elena M; Ballesta A; Marin JL
    Antimicrob Agents Chemother; 1983 Jun; 23(6):897-901. PubMed ID: 6614894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics.
    Ohtani I; Ohtsuki K; Omata T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1978; 40(1):53-63. PubMed ID: 567775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside toxicity in infants and children.
    McCracken GH
    Am J Med; 1986 Jun; 80(6B):172-8. PubMed ID: 3524215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
    Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
    Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
    Moore RD; Smith CR; Lietman PS
    J Infect Dis; 1984 Jan; 149(1):23-30. PubMed ID: 6693788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD; Smith CR; Lipsky JJ; Mellits ED; Lietman PS
    Ann Intern Med; 1984 Mar; 100(3):352-7. PubMed ID: 6364908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.
    Peloquin CA; Berning SE; Nitta AT; Simone PM; Goble M; Huitt GA; Iseman MD; Cook JL; Curran-Everett D
    Clin Infect Dis; 2004 Jun; 38(11):1538-44. PubMed ID: 15156439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
    Moore RD; Lerner SA; Levine DP
    J Infect Dis; 1992 Apr; 165(4):683-8. PubMed ID: 1552197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative overview of randomized trials of aminoglycosides.
    Evans DA; Buring J; Mayrent S; Rosner B; Colton T; Hennekens C
    Am J Med; 1986 Jun; 80(6B):39-43. PubMed ID: 3524219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside.
    Wade JC; Smith CR; Petty BG; Lipsky JJ; Conrad G; Ellner J; Lietman PS
    Lancet; 1978 Sep; 2(8090):604-6. PubMed ID: 80528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ototoxicity of hydroxygentamicin, a new aminoglycoside antibiotic, in guinea pigs.
    Neidl MJ; Liddell MR; Montenaro MJ; Hawkins JE; Drobeck HP
    Fundam Appl Toxicol; 1981; 1(5):395-402. PubMed ID: 7185589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicity of intravitreal aminoglycoside antibiotics.
    D'Amico DJ; Caspers-Velu L; Libert J; Shanks E; Schrooyen M; Hanninen LA; Kenyon KR
    Am J Ophthalmol; 1985 Aug; 100(2):264-75. PubMed ID: 4025468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.